Dr Reddy’s has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).
Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.
In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.
Vohra’s replacement at Dr Reddy’s is the company’s head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.
To fill Sonig’s vacant role Dr Reddy’s has handed MV Ramana, currently executive vice president – emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).